SCHEMBL19559062

SCHEMBL19559062

CCS(CC)(CC)c1cc2cccc(C)c2n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.35
▸ FTO Q9C0B1 1/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ HCRTR1 O43613 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.31
▸ POLB P06746 3/20 0.31
▸ CYP2A6 P11509 2/20 0.31
▸ HTT P42858 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ MCOLN3 Q8TDD5 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ MAPT P10636 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22502897 0.74 ALKBH5 (0.38) ALKBH5FTOCYP1A2MEN1KMT2A
SCHEMBL18685613 0.74 KMT2A (0.46) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL1092872 0.72 ALKBH5 (0.42) ALKBH5FTOCYP1A2MEN1KMT2A
SCHEMBL19559092 0.71 MAPT (0.46) CYP1A2MEN1KMT2AALDH1A1POLB
SCHEMBL19557286 0.70 MEN1 (0.36) ALKBH5FTOCYP1A2MEN1KMT2A
SCHEMBL12355749 0.69 ALKBH5 (0.40) ALKBH5FTOCYP1A2MEN1KMT2A
SCHEMBL25667951 0.69 ALKBH5 (0.40) ALKBH5FTOCYP1A2MEN1KMT2A
SCHEMBL19559066 0.69 KDM4E (0.38) CYP1A2MEN1KMT2ARAB9AALDH1A1
SCHEMBL20739962 0.68 MAPT (0.42) CYP1A2MEN1KMT2ATLR8ALDH1A1
SCHEMBL24188636 0.67 ALKBH5 (0.38) ALKBH5FTOCYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753421-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-09-12 — — US disclosed
US-20220185828-A1 Silylated Derivatives Of Aromatic Heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY 2022-06-16 — — US disclosed
US-11312733-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2022-04-26 — — US disclosed
US-20210047348-A1 Silylated Derivatives Of Aromatic Heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY 2021-02-18 — — US disclosed
US-10919917-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2021-02-16 — — US disclosed
US-10513531-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2019-12-24 — — US disclosed
US-20190048030-A1 SILYLATED DERIVATIVES OF AROMATIC HETEROCYCLES CALIFORNIA INSTITUTE OF TECHNOLOGY 2019-02-14 — — US disclosed
US-20180057514-A1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS CALIFORNIA INSTITUTE OF TECHNOLOGY 2018-03-01 — — US disclosed
US-9809607-B2 Silylation of aromatic heterocycles by earth abundant transition-metal-free catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-11-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11312733-B2 Silylated derivatives of aromatic heterocycles KCNH1, KCNH3, HNRNPH3 ALKBH5 839/4885FTO 2086/4885CYP1A2 1325/4885
US-20180057514-A1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS TEC, AURKA, TYR ALKBH5 770/4885FTO 352/4885CYP1A2 379/4885
US-11753421-B2 Silylated derivatives of aromatic heterocycles KCNH1, KCNH3, HNRNPH3 ALKBH5 839/4885FTO 2086/4885CYP1A2 1325/4885
US-10919917-B2 Silylated derivatives of aromatic heterocycles KCNH1, KCNH3, HNRNPH3 ALKBH5 1086/4885FTO 2458/4885CYP1A2 1203/4885
US-20210047348-A1 Silylated Derivatives Of Aromatic Heterocycles KCNH1, KCNH3, HNRNPH3 ALKBH5 839/4885FTO 2086/4885CYP1A2 1325/4885
US-20220185828-A1 Silylated Derivatives Of Aromatic Heterocycles KCNH1, KCNH3, HNRNPH3 ALKBH5 839/4885FTO 2086/4885CYP1A2 1325/4885
US-10513531-B2 Silylated derivatives of aromatic heterocycles HNRNPH3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SBK3 ALKBH5 2354/4885FTO 2700/4885CYP1A2 1782/4885
US-20190048030-A1 SILYLATED DERIVATIVES OF AROMATIC HETEROCYCLES HNRNPH3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, SBK3 ALKBH5 2354/4885FTO 2700/4885CYP1A2 1782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback